Percutaneous Heart Valve Delivery System with Steerable Sheath

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for mitral and tricuspid regurgitation often require invasive open heart surgery, which is risky and complex, making minimally invasive percutaneous procedures necessary for safer and more efficient treatment, especially for high-risk patients.

Innovation Solution

A delivery system for percutaneous heart valve repair, comprising a steerable sheath, steering mechanism, ball joint mechanism, main knob assembly, stabilizing tool, and actuation mechanism, designed to provide percutaneous access, manipulate, and securely deploy an implant within the heart while ensuring intimate contact and safe retrieval.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If open heart surgery is used to treat mitral and tricuspid regurgitation, then effective treatment can be achieved, but the procedure becomes highly invasive with high risk and complexity

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidsurgical invasiveness
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

A delivery system acts as an intermediary device that transports the implant from outside the body to the target site within the heart through percutaneous access. The delivery system includes a catheter, steering mechanism, and release mechanism that enable minimally invasive deployment of the implant without requiring open heart surgery, thus reducing surgical invasiveness while maintaining treatment effectiveness

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The treatment approach is segmented into separate functional components: the delivery system (catheter, steering mechanism, release mechanism) and the implant (mitral valve repair device or tricuspid valve repair device). This segmentation allows the implant to be delivered and deployed independently through minimally invasive percutaneous access, avoiding the need for complex open heart surgery while maintaining treatment effectiveness

Inventive Principle:
Principle #1Segmentation

2Object-affected harmful factors

If percutaneous procedures are used to treat mitral and tricuspid regurgitation, then surgical risk is reduced, but the complexity of the procedure increases

Engineering Contradiction:
Improvesurgical riskVSAvoidprocedure complexity
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The delivery system serves as an intermediary that simplifies the percutaneous procedure by integrating multiple functions into a single device: navigation through the catheter, positioning via steering mechanism, and deployment through the release mechanism. This integration reduces procedure complexity despite the minimally invasive approach, while simultaneously reducing surgical risk compared to open heart surgery

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The delivery system incorporates feedback mechanisms including the steering mechanism that allows real-time adjustment of catheter position and orientation, and the release mechanism that provides controlled deployment of the implant. These feedback-controlled features enable precise implant placement through percutaneous access, reducing both surgical risk and procedure complexity by providing operator control and verification during the minimally invasive procedure

Inventive Principle:
Principle #23Feedback

Data Source

PatentEP3525864B1Device for delivery of an implant through a catheter
Publication Date: 2023.06.28 VALCARE INC
  • EP3525864B1 patent drawingFigure 1~2
  • EP3525864B1 patent drawingFigure 3~4
  • EP3525864B1 patent drawingFigure 5~6

AI summary

Disclosed herein is a delivery system for percutaneous heart valve repair, the delivery system including a steerable sheath configured to provide percutaneous access into a heart and to deliver an implant. The system may also have a steering mechanism configured to manipulate and orient the implant, a ball joint mechanism configured to connect the steerable sheath to the steering mechanism, a main knob assembly configured to advance and retract a multilumen shaft assembly, a stabilizing tool including a plurality of prongs configured to engage the implant within the heart to make an intimate contact with the heart tissue using a stabilizer and a tongue assembly, and a back assembly including: the actuation mechanism, a suture routing mechanism, a tip lock mechanism, and a back cover configured to protect all sutures being cut by mistake.